Amyloid oligomers: Dynamics and toxicity in the cytosol and nucleus

FEBS Journal

Volumn 277, Issue 6, 2010, Pages 1369-1379

  Kitamura, Akira ^a   Kubota, Hiroshi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Live cell imaging; Misfolded protein; Molecular chaperone; Neurodegenerative disease; Neuronal cell death; Oligomer; Protein aggregation; Protein degradation; Protein interaction; Spectroscopic analysis

Indexed keywords

AMYLOID; CHAPERONE; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; MONOMER; OLIGOMER; POLYGLUTAMINE;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYTIC METHOD; CELL NUCLEUS; CYTOSOL; CYTOTOXICITY; DEGENERATIVE DISEASE; FLUORESCENCE CORRELATION SPECTROSCOPY; FLUORESCENCE LOSS IN PHOTOBLEACHING; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HYDROPHOBICITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SHORT SURVEY;

AMYLOID; AMYOTROPHIC LATERAL SCLEROSIS; CELL NUCLEUS; CYTOSOL; HUMANS; MACROMOLECULAR SUBSTANCES; NEURODEGENERATIVE DISEASES; PEPTIDES; PROTEIN FOLDING; SOLUBILITY;

EID: 77749316908     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07570.x     Document Type: Short Survey

References (77)

1. Taylor JP, Hardy J Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991 1995.
2. Ross CA Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med Suppl 10, S10 S17.
3. Chiti F Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75, 333 366.
4. Gatchel JR Zoghbi HY (2005) Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6, 743 755.
5. Williams AJ Paulson HL (2008) Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci 31, 521 528.
6. Boillee S, Vande Velde C Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39 59.
7. Shaw BF Valentine JS (2007) How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci 32, 78 85.
8. Lippincott-Schwartz J, Snapp E Kenworthy A (2001) Studying protein dynamics in living cells. Nat Rev Mol Cell Biol 2, 444 456.
9. Rigler R, Mets U, Widengren J Kask P (1993) Fluorescence correlation spectroscopy with high count rate and low background: analysis of translational diffusion. Eur Biophys J 22, 169 175.
10. Kim SA Schwille P (2003) Intracellular applications of fluorescence correlation spectroscopy: prospects for neuroscience. Curr Opin Neurobiol 13, 583 590.
11. Sakahira H, Breuer P, Hayer-Hartl MK Hartl FU (2002) Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci U S A 99 Suppl 4, 16412 16418.
12. Muchowski PJ Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6, 11 22.
13. Morimoto RI (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22, 1427 1438.
14. Powers ET, Morimoto RI, Dillin A, Kelly JW Balch WE (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78, 959 991.
15. Ross CA Poirier MA (2005) Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6, 891 898.
16. Ciechanover A Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427 446.
17. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10, 524 530.
18. Arrasate M, Mitra S, Schweitzer ES, Segal MR Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805 810.
19. Matsumoto G, Stojanovic A, Holmberg CI, Kim S Morimoto RI (2005) Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol 171, 75 85.
20. Kim S, Nollen EA, Kitagawa K, Bindokas VP Morimoto RI (2002) Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4, 826 831.
21. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, Schwartz SL, DiProspero NA, Knight MA, Schuldiner O et al. (2007) HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859 863.
22. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727 738.
23. Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780 786.
24. Mizushima N, Levine B, Cuervo AM Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451, 1069 1075.
25. Shibata M, Lu T, Furuya T, Degterev A, Mizushima N, Yoshimori T, MacDonald M, Yankner B Yuan J (2006) Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 281, 14474 14485.
26. Iwata A, Riley BE, Johnston JA Kopito RR (2005) HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280, 40282 40292.
27. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885 889.
28. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S et al. (2007) Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149 1163.
29. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H Johansen T (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171, 603 614.
30. Gal J, Strom AL, Kwinter DM, Kilty R, Zhang J, Shi P, Fu W, Wooten MW Zhu H (2009) Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J Neurochem 111, 1062 1073.
31. Ross CA (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35, 819 822.
32. Bates G (2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642 1644.
33. Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D Housman D (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A 96, 11404 11409.
34. Perutz MF, Finch JT, Berriman J Lesk A (2002) Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci U S A 99, 5591 5595.
35. Nagai Y, Inui T, Popiel HA, Fujikake N, Hasegawa K, Urade Y, Goto Y, Naiki H Toda T (2007) A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol 14, 332 340.
36. Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T Tanaka M (2009) Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci U S A 106, 9679 9684.
37. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK Hartl FU (2000) Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A 97, 7841 7846.
38. Cummings CJ, Sun Y, Opal P, Antalffy B, Mestril R, Orr HT, Dillmann WH Zoghbi HY (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 10, 1511 1518.
39. Schaffar G, Breuer P, Boteva R, Behrends C, Tzvetkov N, Strippel N, Sakahira H, Siegers K, Hayer-Hartl M Hartl FU (2004) Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol Cell 15, 95 105.
40. Kubota S, Kubota H Nagata K (2006) Cytosolic chaperonin protects folding intermediates of Gbeta from aggregation by recognizing hydrophobic beta-strands. Proc Natl Acad Sci U S A 103, 8360 8365.
41. Nollen EA, Garcia SM, van Haaften G, Kim S, Chavez A, Morimoto RI Plasterk RH (2004) Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc Natl Acad Sci U S A 101, 6403 6408.
42. Kitamura A, Kubota H, Pack CG, Matsumoto G, Hirayama S, Takahashi Y, Kimura H, Kinjo M, Morimoto RI Nagata K (2006) Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nat Cell Biol 8, 1163 1170.
43. Behrends C, Langer CA, Boteva R, Bottcher UM, Stemp MJ, Schaffar G, Rao BV, Giese A, Kretzschmar H, Siegers K et al. (2006) Chaperonin TRiC Promotes the Assembly of polyQ Expansion Proteins into Nontoxic Oligomers. Mol Cell 23, 887 897.
44. Tam S, Geller R, Spiess C Frydman J (2006) The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol 8, 1155 1162.
45. Lagier-Tourenne C Cleveland DW (2009) Rethinking ALS: the FUS about TDP-43. Cell 136, 1001 1004.
46. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59 62.
47. Cleveland DW Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2, 806 819.
48. Hart PJ (2006) Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr Opin Chem Biol 10, 131 138.
49. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, Rutkowski DT, Kaufman RJ, Ruse CI, Yates JR 3rd. et al. (2009) Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci U S A 106, 1392 1397.
50. Wang J, Farr GW, Hall DH, Li F, Furtak K, Dreier L Horwich AL (2009) An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet 5, e1000350.
51. Klein WL (2006) Synaptic targeting by Abeta oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease. Alzheimers Dement 2, 43 55.
52. Haass C Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101 112.
53. Ferreira ST, Vieira MN De Felice FG (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59, 332 345.
54. Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R Julien JP (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9, 108 118.
55. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H Cleveland DW (2008) Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11, 251 253.
56. Furukawa Y, Kaneko K, Yamanaka K, O'Halloran TV Nukina N (2008) Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J Biol Chem 283, 24167 24176.
57. Teilum K, Smith MH, Schulz E, Christensen LC, Solomentsev G, Oliveberg M Akke M (2009) Transient structural distortion of metal-free Cu/Zn superoxide dismutase triggers aberrant oligomerization. Proc Natl Acad Sci U S A 106, 18273 18278.
58. Chai Y, Shao J, Miller VM, Williams A Paulson HL (2002) Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci U S A 99, 9310 9315.
59. Stenoien DL, Mielke M Mancini MA (2002) Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat Cell Biol 4, 806 810.
60. Irwin S, Vandelft M, Pinchev D, Howell JL, Graczyk J, Orr HT Truant R (2005) RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci 118, 233 242.
61. Kaganovich D, Kopito R Frydman J (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454, 1088 1095.
62. Pack C, Saito K, Tamura M Kinjo M (2006) Microenvironment and effect of energy depletion in the nucleus analyzed by mobility of multiple oligomeric EGFPs. Biophys J 91, 3921 3936.
63. Takahashi Y, Okamoto Y, Popiel HA, Fujikake N, Toda T, Kinjo M Nagai Y (2007) Detection of polyglutamine protein oligomers in cells by fluorescence correlation spectroscopy. J Biol Chem 282, 24039 24048.
64. Bacia K, Kim SA Schwille P (2006) Fluorescence cross-correlation spectroscopy in living cells. Nat Methods 3, 83 89.
65. Hirose M, Tohda H, Giga-Hama Y, Tsushima R, Zako T, Iizuka R, Pack C, Kinjo M, Ishii N Yohda M (2005) Interaction of a small heat shock protein of the fission yeast, Schizosaccharomyces pombe, with a denatured protein at elevated temperature. J Biol Chem 280, 32586 32593.
66. Rajan RS, Illing ME, Bence NF Kopito RR (2001) Specificity in intracellular protein aggregation and inclusion body formation. Proc Natl Acad Sci U S A 98, 13060 13065.
67. Brignull HR, Moore FE, Tang SJ Morimoto RI (2006) Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J Neurosci 26, 7597 7606.
68. Pollitt SK, Pallos J, Shao J, Desai UA, Ma AA, Thompson LM, Marsh JL Diamond MI (2003) A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor. Neuron 40, 685 694.
69. Takahashi T, Kikuchi S, Katada S, Nagai Y, Nishizawa M Onodera O (2008) Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet 17, 345 356.
70. Mukai H, Isagawa T, Goyama E, Tanaka S, Bence NF, Tamura A, Ono Y Kopito RR (2005) Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc Natl Acad Sci U S A 102, 10887 10892.
71. Wong SL, Chan WM Chan HY (2008) Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration. FASEB J 22, 3348 3357.
72. Yasuda R (2006) Imaging spatiotemporal dynamics of neuronal signaling using fluorescence resonance energy transfer and fluorescence lifetime imaging microscopy. Curr Opin Neurobiol 16, 551 561.
73. Ganesan S, Ameer-Beg SM, Ng TT, Vojnovic B Wouters FS (2006) A dark yellow fluorescent protein (YFP)-based Resonance Energy-Accepting Chromoprotein (REACh) for Forster resonance energy transfer with GFP. Proc Natl Acad Sci U S A 103, 4089 4094.
74. Ganesan S, Rohde G, Eckermann K, Sroka K, Schaefer MK, Dohm CP, Kermer P, Haase G, Wouters F, Bahr M et al. (2008) Mutant SOD1 detoxification mechanisms in intact single cells. Cell Death Differ 15, 312 321.
75. Johnston JA, Dalton MJ, Gurney ME Kopito RR (2000) Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 97, 12571 12576.
76. Niwa J, Yamada S, Ishigaki S, Sone J, Takahashi M, Katsuno M, Tanaka F, Doyu M Sobue G (2007) Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem 282, 28087 28095.
77. Mukhopadhyay S, Krishnan R, Lemke EA, Lindquist S Deniz AA (2007) A natively unfolded yeast prion monomer adopts an ensemble of collapsed and rapidly fluctuating structures. Proc Natl Acad Sci U S A 104, 2649 2654.